[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Ma et al., 2011 - Google Patents

The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model

Ma et al., 2011

View HTML
Document ID
11162293640381573400
Author
Ma H
Yao Q
Zhang A
Lin S
Wang X
Wu L
Sun J
Chen Z
Publication year
Publication venue
Molecules

External Links

Snippet

Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Clinical and laboratory studies have suggested that multi-targeting approaches against neoplastic cells could help to increase patient survival and might reduce the emergence of …
Continue reading at www.mdpi.com (HTML) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/01—Social networking
    • G—PHYSICS
    • G06—COMPUTING; CALCULATING; COUNTING
    • G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
    • G06Q50/10—Services
    • G06Q50/22—Health care, e.g. hospitals; Social work

Similar Documents

Publication Publication Date Title
Ma et al. The effects of artesunate on the expression of EGFR and ABCG2 in A549 human lung cancer cells and a xenograft model
Liao et al. Tetrandrine interaction with ABCB1 reverses multidrug resistance in cancer cells through competition with anti-cancer drugs followed by downregulation of ABCB1 expression
Zhang et al. Osimertinib (AZD9291), a mutant-selective EGFR inhibitor, reverses ABCB1-mediated drug resistance in cancer cells
Houh et al. The effects of artemisinin on the cytolytic activity of natural killer (NK) cells
Correia et al. Study of new therapeutic strategies to combat breast cancer using drug combinations
Suenaga et al. Loss of tumor suppressor CYLD expression triggers cisplatin resistance in oral squamous cell carcinoma
Kung et al. Piperlongumine, a potent anticancer phytotherapeutic, induces cell cycle arrest and apoptosis in vitro and in vivo through the ROS/Akt pathway in human thyroid cancer cells
Salmaggi et al. Synergistic effect of perampanel and temozolomide in human glioma cell lines
Geisen et al. Molecular mechanisms by which a Fucus vesiculosus extract mediates cell cycle inhibition and cell death in pancreatic cancer cells
Giacomini et al. Inhibition of the FGF/FGFR system induces apoptosis in lung cancer cells via c-Myc downregulation and oxidative stress
Jakubzig et al. Mechanisms of matrix-induced chemoresistance of breast cancer cells—deciphering novel potential targets for a cell sensitization
Zhang et al. Knockdown of Akt sensitizes osteosarcoma cells to apoptosis induced by cisplatin treatment
Kuo et al. The deubiquitinating enzyme inhibitor PR-619 enhances the cytotoxicity of cisplatin via the suppression of anti-apoptotic Bcl-2 protein: in vitro and in vivo study
Yu et al. Autophagy modulation in human thyroid cancer cells following aloperine treatment
Chou et al. Combination therapy of chloroquine and C2-ceramide enhances cytotoxicity in lung cancer H460 and H1299 cells
Ji et al. Rutacecarpine inhibits angiogenesis by targeting the VEGFR2 and VEGFR2-mediated Akt/mTOR/p70s6k signaling pathway
Wińska et al. Synergistic interactions of 5-fluorouracil with inhibitors of protein kinase CK2 correlate with p38 MAPK activation and FAK inhibition in the triple-negative breast cancer cell line
Ji et al. The novel triazolonaphthalimide derivative LSS-11 synergizes the anti-proliferative effect of paclitaxel via STAT3-dependent MDR1 and MRP1 downregulation in chemoresistant lung cancer cells
Oh et al. Fascaplysin sensitizes anti-cancer effects of drugs targeting AKT and AMPK
Gaule et al. Dasatinib treatment increases sensitivity to c-met inhibition in triple-negative breast cancer cells
Fontana et al. Exploiting the metabolic consequences of PTEN loss and akt/hexokinase 2 hyperactivation in prostate cancer: a new role for δ-tocotrienol
Lee et al. Combined poziotinib with manidipine treatment suppresses ovarian cancer stem-cell proliferation and stemness
Salucci et al. The cytotoxic effect of curcumin in rhabdomyosarcoma is associated with the modulation of AMPK, AKT/mTOR, STAT, and p53 signaling
Jo et al. Alloferon affects the chemosensitivity of pancreatic cancer by regulating the expression of SLC6A14
He et al. Luteoloside Induces G0/G1 phase arrest of neuroblastoma cells by targeting p38 MAPK